Dr. Mark James Jameson, MD, PhD

Dr. Jameson practices at Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health.

Dr. Jameson's NPI, 1073564993, was assigned on May 15, 2006. Dr. Jameson holds South Dakota license 13192.

Dr. Jameson's primary practice is Avera McKennan Hospital & University Health Center, at 1325 S Cliff Ave Post Office Box 5045, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 322-8000.

Dr. Jameson's primary practice is Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health. Dr. Jameson is also affiliated with Avera St. Luke's Hospital. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Jameson to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jameson practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Jameson's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Jameson's licenses on file in 2 states: South Dakota and Virginia.

CMS data shows 334 Medicare services from Dr. Jameson across 7 procedure codes in 2024, for 190 Medicare patients. Medicare paid $23,346 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 190 Medicare patients who saw Dr. Jameson in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jameson's median patient age at 69, with 35% women.

In 2024, Dr. Jameson wrote 80 Medicare Part D claims for 34 patients. 100% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $456 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

Dr. Jameson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of melanoma (skin cancer) excision by Dr. Jameson, more than 79% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Jameson, published from 2010 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Dr. Jameson has published most often in Laryngoscope. Dr. Jameson's most frequent co-authors are David C. Shonka, MD, Amir Allak, MD and Deepa Danan, MD.

Dmand AI links Dr. Jameson to 3 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Hypocalcemia, Papillomavirus Infections and Squamous Cell Carcinoma of Head and Neck.

CMS Open Payments shows 54 general payments to Dr. Jameson from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,153.